ADA Scientific Sessions 2025
20–23 Jun 2025ChicagoDiabetes supplement2,159 abstracts · 448 worth reading
Abstracts
ADA Scientific Sessions 2025 AbstractAnimals
Uncovering the Mechanisms of Brown Adipose Tissue Aging Using Spatially Resolved Single-Nucleus Transcriptomics
ADA Scientific Sessions 2025 AbstractHuman trial
A Two-Year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance
ADA Scientific Sessions 2025 AbstractAnimals
Muscle mTOR Activation Attenuates Cardiomyopathy and Extends Lifespan in Muscle-Specific IRS1/IRS2 Knockout Mice
ADA Scientific Sessions 2025 AbstractAnimals
Posttranslational Modification of Adipose Tissue Aging and Metabolic Dysregulation by the Methyltransferase SETD2
ADA Scientific Sessions 2025 AbstractCells
Functional Analysis of NUPR1 in Age-Associated Changes in β-Cell Proliferation and Apoptosis
ADA Scientific Sessions 2025 AbstractAnimals
Targeting REV-ERBα to Enhance Glucose Regulation and Address Aging-Related Muscle Dysfunction
ADA Scientific Sessions 2025 AbstractAnimals
Sexually Dimorphic Microglial Senescence and Inflammatory Mechanisms in Obesity and Prediabetes Induced Cognitive Impairment
ADA Scientific Sessions 2025 AbstractAnimals
Region-Specific Effects of Early Aging on Glucose Metabolism in the Brain
ADA Scientific Sessions 2025 AbstractAnimals
Bistable Regulation of Cellular Heterogeneity Governs Thermogenic Activity
ADA Scientific Sessions 2025 AbstractHuman trial
Metformin Improves Brain Glucose Uptake, Network Connectivity, and Volume Concurrent to Improved Working Memory and Processing Speed in Insulin-Resistant Older Adults
ADA Scientific Sessions 2025 AbstractAnimals
IL-1 and IL-6 Impair Proinsulin Maturation in Aging Mice via Downregulation of Prohormone Convertases
ADA Scientific Sessions 2025 AbstractHuman trial
Benefit of an Intensive Lifestyle Intervention on All-Cause Mortality over Two Decades in Older Adults with Diabetes and Overweight/Obesity—The Look AHEAD Study
ADA Scientific Sessions 2025 AbstractCells
Lipocalin-2 Regulates the Function of Phosphatidic Acid in Senescence and mTOR Signaling in Adipose Stromal-Vascular Cells
ADA Scientific Sessions 2025 AbstractAnimals
Senolysis in Pancreatic β-Cells Improves Islet Transplantation Outcomes in Preclinical Models of Diabetes Mellitus
ADA Scientific Sessions 2025 AbstractAnimals
Characterizing the Gut Microbiome, Gut Epithelium, and Glucose Metabolism in Nulliparous and Parous-Aged Female Mice
ADA Scientific Sessions 2025 AbstractCells
Targeting β-Cell Senescence and Secondary Senescence—Therapeutic Potential of JAK Inhibitors in Diabetes
ADA Scientific Sessions 2025 AbstractIn silico
Universal Access to GLP1-RAs Could Reduce Global Obesity Prevalence by 20% and Save 28 Million Lives over Five Years—A Microsimulation Study
ADA Scientific Sessions 2025 AbstractHumans
Association of Dietary Vitamin E Intake with All-Cause and Cause-Specific Mortality among the U.S. Diabetic Population
ADA Scientific Sessions 2025 AbstractHuman trial
Physical Exercise Associated or Not with Taurine Supplementation—Impacts on Metabolic Health in Older Women with Sarcopenic Obesity
ADA Scientific Sessions 2025 AbstractHumans
Impact of Glucose Tolerance on Muscle Mass and Strength in Community-Dwelling Older Adults—Five-Year Changes
ADA Scientific Sessions 2025 AbstractHuman trial
Forty-Weeks of Metformin Improves Glucose Tolerance without Alterations in Skeletal Muscle Mitochondrial Function and Aerobic Capacity
ADA Scientific Sessions 2025 AbstractHumans
Age at Type 2 Diabetes Diagnosis and Mortality and Cardiovascular Risks, and Years of Life Lost in South Asians
ADA Scientific Sessions 2025 AbstractHumans
Impact of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1RAs) on Survival among Cancer Survivors with Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractHuman trial
Taurine Supplementation Combined with Multicomponent Training Reduces Adipocyte Area in Older Women with Sarcopenic Obesity
ADA Scientific Sessions 2025 AbstractHuman trial
Diab@ease—A Pilot Study on Holistic Mental Health Integration for Diabetes, Cognitive Function, and Physical Frailty
ADA Scientific Sessions 2025 AbstractReview
Systematic Review and Meta-analysis of the Association of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Dementia in Patients with Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractHumans
Association of Pancreas Volume with Adverse Clinical Outcomes
ADA Scientific Sessions 2025 AbstractHumans
Cognitive Outcomes in Adults Treated with GLP-1 Receptor Agonists Compared with Nonusers—A Retrospective Chart Review
ADA Scientific Sessions 2025 AbstractHumans
Comparative Effectiveness of Empagliflozin vs. DPP-4i on MACE, HHF, and Mortality across Demographic Factors
ADA Scientific Sessions 2025 AbstractHumans
Impaired Sit-to-Stand Performance and Increased Diabetes Risk—Insights from the Korean Genome and Epidemiology Study
ADA Scientific Sessions 2025 AbstractAnimals
Advanced Age in Spontaneously Hypertensive Rats Induces Prediabetes by Alterations in Pancreatic Islets
ADA Scientific Sessions 2025 AbstractHumans
The Role of Dietary Patterns and Diabetes in Modulating the Risk of Sarcopenia among Adults in Qatar
ADA Scientific Sessions 2025 AbstractHumans
Predicting Future Development of Type 2 Diabetes Using the EHR-Driven Dysglycemia Risk Score (D-RISK)
ADA Scientific Sessions 2025 AbstractHumans
Reduction of the 10-Year ASCVD Risk in Patients with Overweight or Obesity Treated with Semaglutide 2.4 mg in Routine Clinical Care—A Real-World Study
ADA Scientific Sessions 2025 AbstractHumans
Prediction of the Development of Diabetes and Comorbidities by Time Spent in a Unipodal Stance with Eyes Closed
ADA Scientific Sessions 2025 AbstractHumans
The High One-Hour Plasma Glucose Predicts Type 2 Diabetes and Is Determined by Genetic and Lifestyle Factors
ADA Scientific Sessions 2025 AbstractHumans
ADA Presidents' Select Abstract: Heterogeneous Treatment Effects of the VA MOVE! Weight Management Program in Preventing Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractHumans
All-Cause Mortality and GI Adverse Effects in Adults with Type 1 Diabetes (T1D) on GLP-1RA
ADA Scientific Sessions 2025 AbstractHumans
Handgrip Strength and Glucose Metabolism on the Risk of Cerebrovascular Accidents and All-Cause Mortality
ADA Scientific Sessions 2025 AbstractHumans
Improved Polygenic Risk Prediction for Type 2 Diabetes through a GWAS Meta-analysis of over 200,000 Latin American Individuals
ADA Scientific Sessions 2025 AbstractHuman trial
Comparing Models for Predicting Diabetes Progression and Cardiovascular Disease in Risk Stratification and Drug Selection for Prediabetes
ADA Scientific Sessions 2025 AbstractHumans
AI-Based SHAP Clustering Identifies High-Risk Subgroups for Type 2 Diabetes in a Korean Cohort
ADA Scientific Sessions 2025 AbstractHumans
Enhancing Cardiovascular Disease (CVD) Risk Prediction Using Metabolic Profiling in the UK Biobank—Pooled Cohort Equations vs. Retinal Imaging Based Dr. Noon CVD
ADA Scientific Sessions 2025 AbstractHumans
Machine Learning Predicts T2DM Incidence Using Basic Clinical and Laboratory Parameters
ADA Scientific Sessions 2025 AbstractHumans
Development and Validation of a Mortality Risk Prediction Model Using Large-Scale Data from 900,000 Korean Older Adults with Diabetes
ADA Scientific Sessions 2025 AbstractHumans
Assessing the Real-World Effectiveness of the VA MOVE! Lifestyle Program in Preventing Type 2 Diabetes—A 15-Year Follow-up Study
ADA Scientific Sessions 2025 AbstractHumans
Associations between Insulin Secretory Function and Atherosclerotic Cardiovascular Disease Risk
ADA Scientific Sessions 2025 AbstractHumans
Childhood Exposure to Parental Substance Abuse and Adult-Onset Diabetes
ADA Scientific Sessions 2025 AbstractHuman trial
Minimal Weight Loss to Achieve Diabetes Prevention after a Six-Month Intervention in the Korean Diabetes Prevention Study
ADA Scientific Sessions 2025 AbstractHumans
Association between Neck-to-Limb Length and Neck-to-Height Ratios and Cardiovascular Events in a Chinese Population
ADA Scientific Sessions 2025 AbstractHumans
Comparison of Digital Biomarkers for Insulin Resistance and Fatty Liver Scores in Predicting Incident Fatty Liver and Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractHuman trial
Association of Plasma Sphingosine and Sphingomyelin with Incident Diabetes in the Diabetes Prevention Program (DPP) and Outcomes Study (DPPOS)
ADA Scientific Sessions 2025 AbstractHumans
Real-World Effectiveness of the Diabetes Prevention Program—Insights from the REALITY Research Network
ADA Scientific Sessions 2025 AbstractHuman trial
Culturally Tailored Exercise Intervention for Sustained Weight Loss and Increased Functional Mobility in Obese African-American Women
ADA Scientific Sessions 2025 AbstractHumans
Comparing Surrogate Indexes for Insulin Sensitivity/Resistance as Predictors of Type 2 Diabetes (T2D)
ADA Scientific Sessions 2025 AbstractIn silico
Real-Time Early Diabetes Detection Using Saudi Insurance Claims Data—Development and Validation of a Predictive System
ADA Scientific Sessions 2025 AbstractHumans
AI-Based Noninvasive Retinal Imaging for CKD Risk Prediction in DM Patients without Established CKD
ADA Scientific Sessions 2025 AbstractHumans
Natriuretic Peptide Screening Predicts Survival Outcomes in Individuals with Diabetes without Known Heart Failure
ADA Scientific Sessions 2025 AbstractHumans
Sweetened Beverage Intake Is Associated with Increased Risk of Type 2 Diabetes in an Australian Population—A Longitudinal Study
ADA Scientific Sessions 2025 AbstractHumans
Comparison of Subcutaneous, Visceral, Liver, and Muscle Fat Depots in Relation to Diabetes Risk—A Prospective Cohort Study
ADA Scientific Sessions 2025 AbstractHumans
Assessing Fairness of QPrediction Models Using UK Biobank Data
ADA Scientific Sessions 2025 AbstractIn silico
Leveraging Routinely Collected Health Data and Social and Behavioral Determinants of Health in Building Machine-Learning Tools for Diabetes Screening
ADA Scientific Sessions 2025 AbstractIn silico
Eligibility, Impact, and Costs for Tirzepatide for the Primary Prevention of Diabetes Mellitus
ADA Scientific Sessions 2025 AbstractHuman trial
Metabolic Effects of Time-Restricted Eating and Exercise
ADA Scientific Sessions 2025 AbstractHumans
Longitudinal Association between Metabolic States and Cognitive Function in Middle-Aged and Older Chinese Adults—Insights from CHARLS
ADA Scientific Sessions 2025 AbstractHuman trial
Impact of Semaglutide on Kidney, Cardiovascular, and Mortality Outcomes by Baseline BMI and Weight Loss in People with T2D and CKD—Data from the FLOW Trial
ADA Scientific Sessions 2025 AbstractHumans
Impact of SGLT2 Inhibitors with ARB or ACE Inhibitors on Cardiorenal Outcomes in Type 2 Diabetes without Preexisting Cardiovascular or Renal Disease
ADA Scientific Sessions 2025 AbstractHumans
Comparative Effectiveness of Structured Interventions in the Korean Diabetes Prevention Study (KDPS) vs. the Korean Genome and Epidemiology Study (KOGES)
ADA Scientific Sessions 2025 AbstractHumans
Combining 1-Hour Plasma Glucose and Fasting Plasma Glucose to Improve Diabetes Detection in Africans—The Africans in America Study
ADA Scientific Sessions 2025 AbstractHumans
Comparison of Overweight Definitions Using WtHR and BMI—Insights from the Taiwan Lifestyle Study
ADA Scientific Sessions 2025 AbstractIn silico
Clinical Validation of an AI Predictive System for Diabetes Risk in KSA—A Comparative Study
ADA Scientific Sessions 2025 AbstractHumans
Diabetic Peripheral Neuropathy as a Risk Factor for Brain Disease
ADA Scientific Sessions 2025 AbstractAnimals
Fibro-inflammatory Stromal Cells Produce Atrophy-Inducing Paracrine Factors in a Mouse Model of Diabetic Sarcopenia
ADA Scientific Sessions 2025 AbstractHuman trial
Prediabetes Remission and Cardiovascular Mortality and Morbidity
ADA Scientific Sessions 2025 AbstractHumans
Handgrip Strength and Glucose Metabolism on the Risk of Congestive Heart Failure—Insights from a Nationwide Cohort Study
ADA Scientific Sessions 2025 AbstractHumans
Iron, Iron Overload Genes, and Diabetes Risk in African Americans
ADA Scientific Sessions 2025 AbstractHumans
Resistance Training Prevents the Progression of Diabetec Nephropathy in Patients with 2 Diabetes
ADA Scientific Sessions 2025 AbstractHuman trial
Beta-Cell Preservation with Early Oral Antidiabetic Medications in Prediabetes (PreDM)
ADA Scientific Sessions 2025 AbstractHumans
Development and Validation of a Risk Score for Predicting the Initiation of Dialysis in People with and without Diabetes Mellitus
ADA Scientific Sessions 2025 AbstractHuman trial
Partitioned Polygenic Risk Scores (pPRS), Relationship between Insulin Secretion and Sensitivity, and Incidence of Type 2 Diabetes (T2D) in People with Prediabetes
ADA Scientific Sessions 2025 AbstractHumans
A Prediction Model for Prediabetes and Diabetes Using Easily Obtainable Clinical Data
ADA Scientific Sessions 2025 AbstractHuman trial
High One-Hour Post-load Plasma Glucose Is an Intermediate Condition between NGR and IGR
ADA Scientific Sessions 2025 AbstractHumans
Integrative AI-Based Risk Score for Cardiometabolic Diseases—Comparing Cardiovascular Risk Prediction to the Framingham Score
ADA Scientific Sessions 2025 AbstractHumans
Carbohydrate Eating—Timing, Gut Microbiome, and Cardiometabolic Disease
ADA Scientific Sessions 2025 AbstractHumans
Identification of Prediabetes Subtypes and Their Association with Outcomes Using Six Variables—A Data-Driven Cluster Analysis
ADA Scientific Sessions 2025 AbstractHumans
Early Multisystem Involvement in Prediabetic and Early Diabetic States—Novel Clinical Correlations from a Large-Scale Metabolic Screening
ADA Scientific Sessions 2025 AbstractHumans
Combination Lipid-Lowering Therapy and the Risks of Various Types of Cancers in Patients with Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractHumans
Diet, Gut Microbiota, and Histidine Metabolism toward Imidazole Propionate Production in Relation to Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractHuman trial
Feasibility and Acceptability of 8-Hour Time-Restricted Eating with Aerobic or Resistance Training in Older Adults with Prediabetes and Obesity
ADA Scientific Sessions 2025 AbstractHuman trial
Achieving Prediabetes Remission during Lifestyle Intervention Is More Effective Than Weight Loss for Type 2 Diabetes Prevention
ADA Scientific Sessions 2025 AbstractHuman trial
A Four-Week Treatment with Dapagliflozin Reduces Insulin-Stimulated Renal Glucose Uptake
ADA Scientific Sessions 2025 AbstractHumans
Machine Learning for Prediction of Progression from Prediabetes to Diabetes
ADA Scientific Sessions 2025 AbstractIn silico
Once-Weekly Semaglutide vs. Placebo for the Treatment of Type 2 Diabetes and Chronic Kidney Disease in Denmark—A Long-Term Cost-Effectiveness Analysis Based on Flow
ADA Scientific Sessions 2025 AbstractHumans
Adiponectin as a Novel Biomarker for Progression of Cardiovascular-Kidney-Metabolic Syndrome—Insights from a Longitudinal Cohort Study
ADA Scientific Sessions 2025 AbstractAnimals
The Effects and Mechanisms of Caloric Restriction on Diabetic Peripheral Neuropathy
ADA Scientific Sessions 2025 AbstractHuman trial
A Low-Carbohydrate, Low—Saturated Fat Diet to Treat β-Cell Dysfunction and Insulin Resistance in Asian Indians with Prediabetes—A 24-Week Randomized Trial
ADA Scientific Sessions 2025 AbstractHumans
Arsenic-Related DNA Methylation and Incident Type 2 Diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
ADA Scientific Sessions 2025 AbstractHumans
Leveraging Rare Variant Association Analyses to Develop Polygenic Risk Scores (PRSs) for Type 2 Diabetes (T2D)
ADA Scientific Sessions 2025 AbstractHumans
Epigenome-Wide Association Applied in Early Prediction of Kidney Disease in Diabetes (DKD)—A Pilot Study
ADA Scientific Sessions 2025 AbstractHumans
Incident and Recurrent Gestational Diabetes Mellitus and Risk of Future Type 2 Diabetes—A Cohort Study with a Focus on Asian Women
ADA Scientific Sessions 2025 AbstractHuman trial
Prediction of Atherosclerotic Cardiovascular Disease vs. Heart Failure in Type 2 Diabetes—A Post Hoc Analysis of the REWIND and ORIGIN Trials
ADA Scientific Sessions 2025 AbstractHumans
Risk Factors for Progression to Type 2 Diabetes Postgestational Diabetes —A Retrospective Cohort Study
ADA Scientific Sessions 2025 AbstractHumans
Serum Metabolomic Profiles Link History of Gestational Diabetes Mellitus to Increased Type 2 Diabetes Risk in U.S. Hispanic/Latino Women
ADA Scientific Sessions 2025 AbstractHumans
Sex-Specific Associations of Diabetes and Cognition among Middle-Aged and Older Adults in Puerto Rico
ADA Scientific Sessions 2025 AbstractReview
The Antiobesity Medications and Renal Outcomes, One Answer But with Multiple Implications—A Meta-analysis of Randomized Controlled Trials
ADA Scientific Sessions 2025 AbstractHumans
Joint Effect of Hepatic Steatosis Index and Triglyceride Glucose Index on Cardiorenal Outcomes—A Real-World Study
ADA Scientific Sessions 2025 AbstractHumans
AI-Driven Retinal Imaging for Cardiovascular Risk Stratification in Diabetes—Findings from Ret-CAC Screening at GluCare
ADA Scientific Sessions 2025 AbstractHumans
Oral Glucose Tolerance Test or Continuous Glucose Monitoring for Assessment of Prediabetes State
ADA Scientific Sessions 2025 AbstractHumans
Evolution from the Diabetes Prevention Program Research Trial to the National Diabetes Prevention Program—Lessons in Type 2 Diabetes Prevention
ADA Scientific Sessions 2025 AbstractReview
Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors on Solid Organ Transplant Recipients with Diabetes—A Systematic Review and Meta-analysis
ADA Scientific Sessions 2025 AbstractReview
The Broader Impact of Sotagliflozin—Meta-analysis of Its Efficacy in Diabetes Management, Cardiovascular Risk Reduction, and Renal Outcome
ADA Scientific Sessions 2025 AbstractHumans
Chronic Kidney Disease Amplifies Dementia Risk in Patients with Diabetic Retinopathy—A Korean National Health Information Data-Based Study
ADA Scientific Sessions 2025 AbstractHumans
P-tau217 and Cognitive Function in Long-Duration Type 1 Diabetes
ADA Scientific Sessions 2025 AbstractHumans
ABO Blood Type Modifies Association of Whole Grain Intake with Diabetes—Role of Gut Microbiota and Blood Metabolites
ADA Scientific Sessions 2025 AbstractHumans
Cardiovascular Outcomes Associated with Dulaglutide, Exenatide, Liraglutide, and Semaglutide in Adults with Type 2 Diabetes at Moderate Cardiovascular Risk
ADA Scientific Sessions 2025 AbstractHumans
Large-Scale Multiancestry Recessive GWAS Meta-analysis Identifies Novel Recessive Associations and Improves Polygenic Prediction of Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractHumans
Proteinuria and Progression of Kidney Disease in Patients with T2D Treated with SGLT2i and GLP-1RA—A Target Trial Emulation
ADA Scientific Sessions 2025 AbstractAnimals
The Proteomic Analysis of Intermittent Fasting Alone or with GLP-1RA in NAFLD Rats
ADA Scientific Sessions 2025 AbstractHuman trial
Relationship between Magnitude of Weight Loss and Cardiovascular Outcomes in the Diabetes Prevention Program (DPP) and Its Outcomes Study (DPPOS)
ADA Scientific Sessions 2025 AbstractHuman trial
Association of Tirzepatide with Kidney Parameters in People with Obesity and Prediabetes from SURMOUNT-1 over 176 Weeks
ADA Scientific Sessions 2025 AbstractHuman trial
Early vs. Late Prediabetes Remission during Lifestyle Intervention Is Relevant for Type 2 Diabetes Prevention
ADA Scientific Sessions 2025 AbstractHuman trial
Sustained Weight Reduction by Thresholds in Adults with Obesity and Prediabetes Treated with Tirzepatide over 176 Weeks (SURMOUNT-1)
ADA Scientific Sessions 2025 AbstractHuman trial
Artificial Intelligence vs. Human Coaching for Diabetes Prevention—Results from a 12-Month, Multicenter, Pragmatic Randomized Controlled Trial
ADA Scientific Sessions 2025 AbstractHuman trial
Amycretin, a Novel, Unimolecular GLP-1 and Amylin Receptor Agonist—Results of a Phase 1b/2a Clinical Trial
ADA Scientific Sessions 2025 AbstractHumans
Is Loneliness a Mediator of the Relationship between Discrimination and Dementia in Older Adults with Diabetes in High- and Middle-Income Countries?
ADA Scientific Sessions 2025 AbstractHuman trial
Efficacy and Safety of BGM0504 in Chinese Patients with Obesity—A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
ADA Scientific Sessions 2025 AbstractHumans
Emulation of the Study of Tirzepatide Compared with Dulaglutide on Major Cardiovascular Events in Participants with Type 2 Diabetes (SURPASS-CVOT)
ADA Scientific Sessions 2025 AbstractHumans
Coronary Artery Calcification Incidence in Individuals with Diabetes and BMI <30 kg/m2
ADA Scientific Sessions 2025 AbstractReview
Longitudinal Predictors of Cognitive Impairment in Older Adults with Type 2 Diabetes—A Systematic Review
ADA Scientific Sessions 2025 AbstractHumans
A Metabolome-Derived Score Predicts Metabolic Dysfunction–Associated Steatohepatitis and Mortality from Liver and Metabolic Diseases
ADA Scientific Sessions 2025 AbstractHuman trial
A Phase 3 Evaluation of CAMP-Biased GLP-1 Analog Ecnoglutide in Adults with Overweight or Obesity
ADA Scientific Sessions 2025 AbstractHumans
Phenotypic Heterogeneity and Risk for Type 2 Diabetes in Central European and South Asian People with Prediabetes
ADA Scientific Sessions 2025 AbstractHuman trial
Effects of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids in Subjects with Obesity or Overweight
ADA Scientific Sessions 2025 AbstractHuman trial
Safety, Tolerability, and Pharmacokinetics of HM15275, a Novel GLP-1, GIP, and Glucagon Triple Receptor Agonist—Preliminary Results from a Phase 1 Study
ADA Scientific Sessions 2025 AbstractHumans
Prediabetes—Identifying the Gaps in Diagnosis and Lifestyle Intervention?
ADA Scientific Sessions 2025 AbstractHuman trial
Efficacy and Safety of a Novel Dual GLP-1/GIP Receptor Agonist in Participants with Type 2 Diabetes Mellitus Up to 32 Weeks
ADA Scientific Sessions 2025 AbstractHumans
Enhanced Renal Protective Effects of Tirzepatide in T2D People
ADA Scientific Sessions 2025 AbstractHuman trial
Bofanglutide (GZR18), a Novel GLP-1RA, Improved Glycemic Control and Cardiometabolic Risk Factors in Chinese Patients with T2D
ADA Scientific Sessions 2025 AbstractHumans
SGLT2 Inhibitors or GLP-1 Receptor Agonists? Development of a Personalized Treatment Algorithm for Individuals with Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractIn silico
Cost-Effectiveness of SGLT2i plus GLP-1RAs vs. SGLT2i in Patients with Chronic Kidney Disease
ADA Scientific Sessions 2025 AbstractHumans
The Effect of SGLT2 Inhibitors on Glycemic Control and Renal Outcomes in Adults with Type 1 Diabetes
ADA Scientific Sessions 2025 AbstractHuman trial
Effects of Once-Weekly Utreglutide (GL0034) in Individuals with Overweight and Obesity on Lipid Metabolism—A 10-Week Exploratory Proof-of-Concept Study
ADA Scientific Sessions 2025 AbstractHumans
The Association between Elevated A1C and ASCVD Risk Scores in a Food Insecure Population in Chicago
ADA Scientific Sessions 2025 AbstractHumans
Polygenic Score Predicts Faster Kidney Function Decline in Individuals with and without Diabetes
ADA Scientific Sessions 2025 AbstractHumans
Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages among Middle-Aged and Elderly Chinese Individuals—Evidence from the CHARLS
ADA Scientific Sessions 2025 AbstractHuman trial
Impact of Smartphone-Enabled Home Urine Albuminuria Testing on Albuminuria Screening and Management
ADA Scientific Sessions 2025 AbstractHumans
Examining the Association between Prediabetes and Mortality—The Role of Patient Profiles in Risk Prediction
ADA Scientific Sessions 2025 AbstractHuman trial
Efficacy and Safety of Semaglutide 7.2 mg in Obesity and Type 2 Diabetes—STEP UP T2D Trial
ADA Scientific Sessions 2025 AbstractHuman trial
Efficacy and Safety of a Novel Dual GLP-1/GLP Receptor Agonist in Chinese Overweight or Obese Adults without Diabetes
ADA Scientific Sessions 2025 AbstractAnimals
Estrogen Modulates Obesity Effects on Neurobehavioral Phenotypes in a Female Mouse Model of Alzheimer’s Disease
ADA Scientific Sessions 2025 AbstractHuman trial
Mechanisms of Behavior Change in Diabetes Prevention—Evidence from a Randomized Trial in Women with a History of Gestational Diabetes
ADA Scientific Sessions 2025 AbstractHumans
Assessing Individual Estimated GFR Trajectory on GLP-1RA Use for Kidney Protection
ADA Scientific Sessions 2025 AbstractAnimals
Caloric Restriction Ameliorates MAFLD by Upregulating CREB1-Dependent GSTM3 Expression and Enhancing Mitochondrial Function
ADA Scientific Sessions 2025 AbstractHumans
The Association between New Insulin Resistance Indices and All-Cause Mortality in Elderly DM Patients
ADA Scientific Sessions 2025 AbstractHuman trial
DNA Methylation Biomarkers Associated with Weight Loss Response for Individuals with Prediabetes Based on Korean Diabetes Prevention Study (KDPS)
ADA Scientific Sessions 2025 AbstractHuman trial
Safety, Tolerability, and Clinical Effects of Dapiglutide, a Once-Weekly GLP-1R/GLP-2R Agonist
ADA Scientific Sessions 2025 AbstractHuman trial
Improved Hepatic Insulin Sensitivity and Insulin Secretion in Short-Term Early Time-Restricted Eating in Men with and without Psoriasis
ADA Scientific Sessions 2025 AbstractHuman trial
Integrated Analysis Supports Cardiovascular Safety and Risk Reduction with Pemvidutide Treatment
ADA Scientific Sessions 2025 AbstractAnimals
Exercise-Induced Lactylation of WDR41 Initiates Autophagy and Improves MASLD
ADA Scientific Sessions 2025 AbstractHumans
Association of Glucagon-Like Peptide 1 Receptor Agonists with Cancer Risk in Older Adults with Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractHumans
Ceramides Surpass LDL-Cholesterol in Predicting Cardiovascular Mortality in Patients with as Well as in Patients without the Metabolic Syndrome
ADA Scientific Sessions 2025 AbstractHumans
Reduced Quality of Life among Adults with Diabetes-Related Multimorbidity in India
ADA Scientific Sessions 2025 AbstractHumans
Total and Site-Specific Cancer Risks in Young Obese Adults—Six Million Large-Scale Data from Korean Population
ADA Scientific Sessions 2025 AbstractHuman trial
NA-931, a Novel Quadruple IGF-1-1, GLP-1, GIP, and Glucagon Receptor Agonist Reduces Body Weight without Muscle Loss
ADA Scientific Sessions 2025 AbstractHumans
Metabolic Health, Obesity, and Renal Cell Carcinoma Risk in Korean Young Adults—A Population-Based Cohort Study
ADA Scientific Sessions 2025 AbstractAnimals
The Molecular Signature of Endurance Training in the Brain—A Proteomics Approach
ADA Scientific Sessions 2025 AbstractHuman trial
First Report on the Small Molecule Oral GLP-1 Receptor Agonist RGT-075 in Obesity—A Randomized, Placebo-Controlled Phase 2a Proof-of-Concept Twelve-Week Study
ADA Scientific Sessions 2025 AbstractHuman trial
Effects of a 6-Month Lifestyle Intervention for Type 2 Diabetes Featuring Intermittent Energy Restriction or Time-Restricted Eating on Glucose Tolerance and Body Weight
ADA Scientific Sessions 2025 AbstractAnimals
The Anti-myostatin Antibody SRK-439 Improves Grip Strength during GLP-1RA Treatment in a Mouse Model of Obesity
ADA Scientific Sessions 2025 AbstractHumans
Glucose-6-Phosphate Dehydrogenase Deficiency Masks the Diagnosis of Abnormal Glucose Tolerance by A1C—The Africans in America Study
ADA Scientific Sessions 2025 AbstractHuman trial
Efficacy and Safety of RAY1225 Once Every Two Weeks in Chinese Adults with Obesity or Overweight (REBUILDING-1)
ADA Scientific Sessions 2025 AbstractHumans
Prevalence and Characterization of Underlying Preoperative Dysglycemia in Surgical Patients without Diabetes
ADA Scientific Sessions 2025 AbstractHumans
Semaglutide Is Associated with Lower Risk of Diabetic Retinopathy in a Saudi Cohort with Type 2 Diabetes
ADA Scientific Sessions 2025 AbstractReview
A Meta-analysis of Novel Glucose-Lowering Therapies in Kidney Transplant Recipients with Diabetes
ADA Scientific Sessions 2025 AbstractHumans
Diabetes Prediction without Blood Tests—The Role of Retinal Imaging and Artificial Intelligence
ADA Scientific Sessions 2025 AbstractHuman trial
Diabetes Staging System (DSS)—A Novel Approach to Improve SGLT2i/GLP-1RA Use and CVD/CKD Outcomes in DM2
ADA Scientific Sessions 2025 AbstractHumans
Retrospective Effects of GLP-1 Receptor Agonists with and without Concomitant SGLT2 Inhibitor Use in Diabetic Renal Transplant Recipients after 12 Months
ADA Scientific Sessions 2025 AbstractHuman trial
Sustainability of Waist-Height Ratio in Surmount-1 Three-Year Study
ADA Scientific Sessions 2025 AbstractHumans
Community-Supported Initiative for Diabetes Screening and Management in a Rural Community in Bangladesh
ADA Scientific Sessions 2025 AbstractHumans
Association between the Use of Alpha-lipoic Acid and Macrovascular Complications in Patients with Diabetic Neuropathy
ADA Scientific Sessions 2025 AbstractHumans